Mizoribine inhibits natural antibody production in a discordant xenograft model.
Flores
H C
HC
Department of Surgery, University of Minnesota Medical School, Minneapolis.
Leventhal
J R
JR
Gruber
S A
SA
Schaffer
M M
MM
Bolman
R M
RM
Matas
A J
AJ
D000818:Animals; D000910:Antibodies, Heterophile / Q000032:analysis / Q000096:biosynthesis; D000917:Antibody Formation / Q000187:drug effects; D004797:Enzyme-Linked Immunosorbent Assay; D006084:Graft Rejection; D006168:Guinea Pigs; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D012263:Ribonucleosides / Q000627:therapeutic use*; D013156:Splenectomy; D014183:Transplantation, Heterologous
D000910:Antibodies, Heterophile; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine